ANGPT2 and acute respiratory distress syndrome: These results imply that correcting the imbalances between Ang1 and Ang2 by either administering Ang1 or inhibiting Ang2 may represent a new therapeutic strategy for severe inflammatory illnesses, such as ARDS.